Obamacare's comparative effectiveness research board director Joe Selby said he believes the board is a three to five years away from having a fully functioning network for comparing the effectiveness of health care products and services. Selby, executive director of the Patient-Centered Outcomes Research Group, spoke at a National Pharmaceutical Council webinar Thursday (March 26), where he said more people are realizing the benefits of comparative effectiveness research. “It's like electronic health records. It just has enough obvious value that...